Melanoma trials in Türkiye
5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peoplePharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma
- Where
- Ankara, Bornova, Konak
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Biocon Biologics UK PLC
See details and how to joinNCT07476326 · EU 2025-525158-20-00 - Phase 3Taking peopleStudy to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma
- Where
- Adapazarı, Ankara, Çankaya, Diyarbakır, Eskişehir, Istanbul, Yüreğir
- Age
- 18 years and over
- People
- 632 worldwide
- Run by
- mAbxience Research S.L.
See details and how to joinNCT07221734 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Ankara, Bağcılar, Izmir
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - Phase 1/2Taking peopleA Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Where
- Ankara, Istanbul, Yüreğir
- Age
- 18 years and over
- People
- 1,438 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07070232 · EU 2024-517261-16-00 - Phase 3Taking peopleIMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
- Where
- Altındağ, Ankara, Antalya, Bahçelievler, Bornova, Çankaya, Cordaleo, Kepez, Malatya, Samsun, Şehitkamil, Seyhan, Yenimahalle, Yüreğir
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Immunocore Ltd
See details and how to joinNCT06112314